Find a Physician

Profile http://stanfordhospital.org/profiles/Linda_Boxer/
Email this profile
Portrait View Larger

Linda Boxer, MD, PhD

Academic Appointments

  • Vice Dean of the School of Medicine and Professor of Medicine (Hematology)

Key Documents

Contact Information

  • Clinical Offices
    Hematology Clinic 875 Blake Wilbur Dr Clinic C MC 5820 Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 723-1269
    Hematology Clinic 875 Blake Wilbur Dr Clinic C MC 5820 Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 723-1269
  • Academic Offices
    Personal Information
    Email Tel (650) 724-6966
    Alternate Contact
    Lisa Joo Executive Associate Tel Work 650-725-6762
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Cancer> Hematology
  • Hematology
  • Multiple Myeloma
  • Multiple Myeloma - Medical Oncology
  • Plasmacytoma
  • Plasmacytoma - Hematology
View All 7clinical focus of Linda Boxer

Academic Appointments

Administrative Appointments

  • Chief, Division of Hematology, Stanford University School of Medicine (2004 - present)

Professional Education

Fellowship: Stanford University School of Medicine CA (1990)
Fellowship: Stanford University School of Medicine CA (1989)
Residency: Stanford University School of Medicine CA (1984)
Internship: Stanford University School of Medicine CA (1982)
Board Certification: Medical Oncology, American Board of Internal Medicine (1987)
Board Certification: Internal Medicine, American Board of Internal Medicine (1984)
View All 9

Courses

2013-14

Postdoctoral Advisees

James McClellanAlexander Ungewickell

Graduate and Fellowship Program Affiliations

Scientific Focus

Current Research and Scholarly Interests

We are studying the transcriptional deregulation of several oncogenes in human hematologic malignancies.

Activation of c-myc in Burkitt's lymphoma: We are examining the transcriptional deregulation of the translocated c-myc gene and the silencing of the normal c-myc gene in Burkitt's lymphoma. We are looking at the c-myc promoter and regions of the immunoglobulin locus that are responsible for the deregulation of the translocated c-myc gene. Several model systems have been designed.

Activation of bcl-2 in hematologic malignancies: In lymphomas with the t(14;18) translocation, the bcl-2 gene is translocated to the immunoglobulin locus and expressed at high levels. We are studying the mechanism of activation at a molecular level in human lymphoma tissue. We have also developed a model system to determine which region of the immunoglobulin locus is responsible for the activation of the translocated bcl-2 gene.

Expression profiling in ALL: We are examining gene expression profiles in acute lymphoblastic leukemia in response to chemotherapeutic agents.

Publications

Publication tag cloud

Publication Topics

View All 56

Stanford Medicine Resources:

Footer Links: